Skip to main content

Therapeutics Startups

Updated October 2026

Companies in the therapeutics sector developing innovative solutions and technologies.

Explore 1,723 recently funded therapeutics companies with verified founder contact information and fundraising data.

Total Companies
1,723
Total Funding
$1.3B
Avg Funding
$51.2M
Global Reach
7
countries

Top Cities for Therapeutics

Boston
Hanover
Palo Alto
South San Francisco
San Diego
Charlottesville

Recently Funded Companies

Export
Boston, United States

General Cybernetics is a company that offers technology driven products and services.

$15.3M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Boston, United States

Solstice Oncology develops immuno-oncology therapies focused on treating and preventing cancer through targeted approaches.

$225.0M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Hanover, Germany

Allogenetics provides a unique solution to the problem of organ rejection following transplantation.

$4.4M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Palo Alto, United States

Ridge Biotechnologies is an AI-driven biotechnology company that designs precision enzymes, linkers, and targeted therapeutics.

$13.0M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

South San Francisco, United States

Encoded Therapeutics is a biotechnology company developing genetic medicines for neurological disorders and other diseases.

$275.0M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

San Diego, United States

Iambic is disrupting the therapeutics landscape with its unique AI-driven drug-discovery platform.

$66.0M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Charlottesville, United States

Navion Neurosciences is a pre-clinical stage biotechnology company that develops sodium channel therapeutics for neurological diseases.

$10.8M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Boston, United States

DynamiCare Health is a digital platform helping people monitor and reduce the use of drugs, opioids, alcohol, and tobacco.

$720K raised
Sep 2026

Founder Contacts

41,000+ verified contacts

London, United Kingdom

Epsilogen is a developer of an immuno-oncology company intended to develop immunoglobulin antibodies to treat cancer.

$16.3M raised
Sep 2024

Founder Contacts

41,000+ verified contacts

San Francisco, United States

Blue Note Therapeutics is a prescription digital therapeutics company that merges deep scientific and clinical expertise.

$5.2M raised
Sep 2021

Founder Contacts

41,000+ verified contacts

Tucson, United States

Cairn Therapeutics transforms the treatment of cancer by overcoming the current limitations of the current therapies.

$3.0M raised
Sep 2021

Founder Contacts

41,000+ verified contacts

Copenhagen, Denmark

PanTarg develops antibody-drug conjugates for pancreatic cancer and other solid tumors.

$1.5M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Seattle, United States

BrainChild Bio develops chimeric antigen receptor T-cell therapies engineered to treat tumors of the central nervous system.

$116.0M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Waltham, United States

Korsana Biosciences develops THETA-enabled antibody therapies for neurodegenerative diseases including Alzheimer’s.

$380.0M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Berkeley, United States

KuriBio builds a nanotechnology platform for therapeutic applications in oncology and beyond.

$150K raised
Sep 2024

Founder Contacts

41,000+ verified contacts

San Carlos, United States

Eugit Therapeutics is a biotechnology research company that develops tissue targetting drugs for therapeutic purposes.

$500K raised
Sep 2022

Founder Contacts

41,000+ verified contacts

Cambridge, United States

Photys Therapeutics’ proprietary bifunctional small molecules platform unlocks fine-tuned control of protein modifications.

$75.0M raised
Sep 2022

Founder Contacts

41,000+ verified contacts

Walnut Creek, United States

RecoveryOne provides physical therapy programs for people struggling with musculoskeletal issues.

$33.0M raised
Sep 2021

Founder Contacts

41,000+ verified contacts

Sainte-hélène-du-lac, France

Carroucell is the microcarrier supplier for cell culture in bioreactor.

$1.5M raised
Sep 2022

Founder Contacts

41,000+ verified contacts

Brescia, Italy

Diadem is an innovative blood-based test exploiting a proprietary antibody targeting a specific conformation of p53 protein.

$2.5M raised
Sep 2022

Founder Contacts

41,000+ verified contacts

Washington, United States

Otolith Labs develops a therapeutic device for the treatment of vertigo.

$20.0M raised
Sep 2022

Founder Contacts

41,000+ verified contacts

Copenhagen, Denmark

Ebumab is a biotechnology research company utilizing AMT technology in combination with the body’s own immune system to fight cancer.

$495K raised
Sep 2022

Founder Contacts

41,000+ verified contacts

Charleston, United States

MitoChem Therapeutics develops treatments to address the effects of mitochondrial dysfunction in neurodegenerative, aging, and disease.

$200K raised
Sep 2022

Founder Contacts

41,000+ verified contacts

Melbourne, Australia

OccuRx is a biopharmaceutical company that focuses on the development of innovative therapeutic strategies.

$14.5M raised
Sep 2022

Founder Contacts

41,000+ verified contacts

Copenhagen, Denmark

Solid Therapeutics develops novel cancer therapeutics with dual performance targeting cancer cells and immune cells to treat solid tumors.

Sep 2023

Founder Contacts

41,000+ verified contacts

Showing 1 to 25 of 1,723 companies

About the Therapeutics Startup Ecosystem

The therapeutics sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Therapeutics

Therapeutics companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The therapeutics sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Therapeutics Funding Breakdown

Here is how funding is distributed among the 1,723 therapeutics companies tracked in the VCBacked database.

Average Funding
$51.2M
Total Funding Tracked
$1.3B
Countries Represented
7

Distribution by Funding Stage

Other25 companies

Top Cities for Therapeutics

1.Boston
3 companies$241.0M
2.Copenhagen
3 companies$2.0M
3.Hanover
1 companies$4.4M
4.Palo Alto
1 companies$13.0M
5.South San Francisco
1 companies$275.0M

Related Industries

Companies in the therapeutics sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Therapeutics Startups?

Perfect for: B2B sales teams targeting therapeutics companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked